Table of Contents 1 Rofecoxib Market Overview 1.1 Product Overview and Scope of Rofecoxib 1.2 Rofecoxib Segment by Type 1.2.1 Global Rofecoxib Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Oral Suspension. 1.2.3 Tablet-Form 1.3 Rofecoxib Segment by Application 1.3.1 Rofecoxib Sales Comparison by Application: 2020 VS 2026 1.3.2 Osteoarthritis 1.3.3 Rheumatoid Arthritis 1.3.4 Juvenile Rheumatoid Arthritis 1.3.5 Acute Pain Conditions 1.3.6 Migraine 1.3.7 Dysmenorrhea 1.4 Global Rofecoxib Market Size Estimates and Forecasts 1.4.1 Global Rofecoxib Revenue 2015-2026 1.4.2 Global Rofecoxib Sales 2015-2026 1.4.3 Rofecoxib Market Size by Region: 2020 Versus 2026 2 Global Rofecoxib Market Competition by Manufacturers 2.1 Global Rofecoxib Sales Market Share by Manufacturers (2015-2020) 2.2 Global Rofecoxib Revenue Share by Manufacturers (2015-2020) 2.3 Global Rofecoxib Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Rofecoxib Manufacturing Sites, Area Served, Product Type 2.5 Rofecoxib Market Competitive Situation and Trends 2.5.1 Rofecoxib Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Rofecoxib Players (Opinion Leaders) 3 Rofecoxib Retrospective Market Scenario by Region 3.1 Global Rofecoxib Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Rofecoxib Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Rofecoxib Market Facts & Figures by Country 3.3.1 North America Rofecoxib Sales by Country 3.3.2 North America Rofecoxib Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Rofecoxib Market Facts & Figures by Country 3.4.1 Europe Rofecoxib Sales by Country 3.4.2 Europe Rofecoxib Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Rofecoxib Market Facts & Figures by Region 3.5.1 Asia Pacific Rofecoxib Sales by Region 3.5.2 Asia Pacific Rofecoxib Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Rofecoxib Market Facts & Figures by Country 3.6.1 Latin America Rofecoxib Sales by Country 3.6.2 Latin America Rofecoxib Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Rofecoxib Market Facts & Figures by Country 3.7.1 Middle East and Africa Rofecoxib Sales by Country 3.7.2 Middle East and Africa Rofecoxib Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Rofecoxib Historic Market Analysis by Type 4.1 Global Rofecoxib Sales Market Share by Type (2015-2020) 4.2 Global Rofecoxib Revenue Market Share by Type (2015-2020) 4.3 Global Rofecoxib Price Market Share by Type (2015-2020) 4.4 Global Rofecoxib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Rofecoxib Historic Market Analysis by Application 5.1 Global Rofecoxib Sales Market Share by Application (2015-2020) 5.2 Global Rofecoxib Revenue Market Share by Application (2015-2020) 5.3 Global Rofecoxib Price by Application (2015-2020) 6 Company Profiles and Key Figures in Rofecoxib Business 6.1 Merck 6.1.1 Corporation Information 6.1.2 Merck Description, Business Overview and Total Revenue 6.1.3 Merck Rofecoxib Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Merck Products Offered 6.1.5 Merck Recent Development 6.2 Chengdu Meinkai Chemical Co. LTD 6.2.1 Chengdu Meinkai Chemical Co. LTD Rofecoxib Production Sites and Area Served 6.2.2 Chengdu Meinkai Chemical Co. LTD Description, Business Overview and Total Revenue 6.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Chengdu Meinkai Chemical Co. LTD Products Offered 6.2.5 Chengdu Meinkai Chemical Co. LTD Recent Development 6.3 Wuhan Xinxin Jiali Biotechnology Co. LTD 6.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Production Sites and Area Served 6.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Description, Business Overview and Total Revenue 6.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Products Offered 6.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development 6.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD 6.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Production Sites and Area Served 6.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description, Business Overview and Total Revenue 6.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Products Offered 6.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development 6.5 Pfizer 6.5.1 Pfizer Rofecoxib Production Sites and Area Served 6.5.2 Pfizer Description, Business Overview and Total Revenue 6.5.3 Pfizer Rofecoxib Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Pfizer Products Offered 6.5.5 Pfizer Recent Development 6.6 Tremeau 6.6.1 Tremeau Rofecoxib Production Sites and Area Served 6.6.2 Tremeau Description, Business Overview and Total Revenue 6.6.3 Tremeau Rofecoxib Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Tremeau Products Offered 6.6.5 Tremeau Recent Development 7 Rofecoxib Manufacturing Cost Analysis 7.1 Rofecoxib Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Rofecoxib 7.4 Rofecoxib Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Rofecoxib Distributors List 8.3 Rofecoxib Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Rofecoxib Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Rofecoxib by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Rofecoxib by Type (2021-2026) 10.2 Rofecoxib Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Rofecoxib by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Rofecoxib by Application (2021-2026) 10.3 Rofecoxib Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Rofecoxib by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Rofecoxib by Region (2021-2026) 10.4 North America Rofecoxib Estimates and Projections (2021-2026) 10.5 Europe Rofecoxib Estimates and Projections (2021-2026) 10.6 Asia Pacific Rofecoxib Estimates and Projections (2021-2026) 10.7 Latin America Rofecoxib Estimates and Projections (2021-2026) 10.8 Middle East and Africa Rofecoxib Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Rofecoxib Sales (MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Rofecoxib Sales (MT) Comparison by Application: 2020 VS 2026 Table 3. Global Rofecoxib Market Size by Type (MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Rofecoxib Manufacturers Covered in This Study Table 5. Global Rofecoxib Sales (MT) by Manufacturers (2015-2020) Table 6. Global Rofecoxib Sales Share by Manufacturers (2015-2020) Table 7. Global Rofecoxib Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Rofecoxib Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Rofecoxib Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Rofecoxib Sales Sites and Area Served Table 11. Manufacturers Rofecoxib Product Types Table 12. Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Rofecoxib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rofecoxib as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Rofecoxib Players Table 16. Global Rofecoxib Sales (MT) by Region (2015-2020) Table 17. Global Rofecoxib Sales Market Share by Region (2015-2020) Table 18. Global Rofecoxib Revenue (Million US$) by Region (2015-2020) Table 19. Global Rofecoxib Revenue Market Share by Region (2015-2020) Table 20. North America Rofecoxib Sales by Country (2015-2020) (MT) Table 21. North America Rofecoxib Sales Market Share by Country (2015-2020) Table 22. North America Rofecoxib Revenue by Country (2015-2020) (US$ Million) Table 23. North America Rofecoxib Revenue Market Share by Country (2015-2020) Table 24. Europe Rofecoxib Sales by Country (2015-2020) (MT) Table 25. Europe Rofecoxib Sales Market Share by Country (2015-2020) Table 26. Europe Rofecoxib Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Rofecoxib Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Rofecoxib Sales by Region (2015-2020) (MT) Table 29. Asia Pacific Rofecoxib Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Rofecoxib Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Rofecoxib Revenue Market Share by Region (2015-2020) Table 32. Latin America Rofecoxib Sales by Country (2015-2020) (MT) Table 33. Latin America Rofecoxib Sales Market Share by Country (2015-2020) Table 34. Latin America Rofecoxib Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Rofecoxib Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Rofecoxib Sales by Country (2015-2020) (MT) Table 37. Middle East and Africa Rofecoxib Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Rofecoxib Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Rofecoxib Revenue Market Share by Country (2015-2020) Table 40. Global Rofecoxib Sales (MT) by Type (2015-2020) Table 41. Global Rofecoxib Sales Share by Type (2015-2020) Table 42. Global Rofecoxib Revenue (Million US$) by Type (2015-2020) Table 43. Global Rofecoxib Revenue Share by Type (2015-2020) Table 44. Global Rofecoxib Price (USD/MT) by Type (2015-2020) Table 45. Global Rofecoxib Sales (MT) by Application (2015-2020) Table 46. Global Rofecoxib Sales Market Share by Application (2015-2020) Table 47. Global Rofecoxib Sales Growth Rate by Application (2015-2020) Table 48. Merck Rofecoxib Corporation Information Table 49. Merck Description and Business Overview Table 50. Merck Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Merck Main Product Table 52. Merck Recent Development Table 53. Chengdu Meinkai Chemical Co. LTD Rofecoxib Corporation Information Table 54. Chengdu Meinkai Chemical Co. LTD Corporation Information Table 55. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Chengdu Meinkai Chemical Co. LTD Main Product Table 57. Chengdu Meinkai Chemical Co. LTD Recent Development Table 58. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Corporation Information Table 59. Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information Table 60. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Wuhan Xinxin Jiali Biotechnology Co. LTD Main Product Table 62. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development Table 63. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Corporation Information Table 64. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information Table 65. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Product Table 67. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development Table 68. Pfizer Rofecoxib Corporation Information Table 69. Pfizer Corporation Information Table 70. Pfizer Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Pfizer Main Product Table 72. Pfizer Recent Development Table 73. Tremeau Rofecoxib Corporation Information Table 74. Tremeau Corporation Information Table 75. Tremeau Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Tremeau Main Product Table 77. Tremeau Recent Development Table 78. Sales Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Rofecoxib Distributors List Table 81. Rofecoxib Customers List Table 82. Market Key Trends Table 83. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 84. Key Challenges Table 85. Global Rofecoxib Sales (MT) Forecast by Type (2021-2026) Table 86. Global Rofecoxib Sales Market Share Forecast by Type (2021-2026) Table 87. Global Rofecoxib Revenue (Million US$) Forecast by Type (2021-2026) Table 88. Global Rofecoxib Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 89. Global Rofecoxib Sales (MT) Forecast by Application (2021-2026) Table 90. Global Rofecoxib Revenue (Million US$) Forecast by Application (2021-2026) Table 91. Global Rofecoxib Sales (MT) Forecast by Region (2021-2026) Table 92. Global Rofecoxib Sales Market Share Forecast by Region (2021-2026) Table 93. Global Rofecoxib Revenue Forecast by Region (2021-2026) (US$ Million) Table 94. Global Rofecoxib Revenue Market Share Forecast by Region (2021-2026) Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Rofecoxib Figure 2. Global Rofecoxib Sales Market Share by Type: 2020 VS 2026 Figure 3. Oral Suspension. Product Picture Figure 4. Tablet-Form Product Picture Figure 5. Global Rofecoxib Consumption Market Share by Application: 2020 VS 2026 Figure 6. Osteoarthritis Figure 7. Rheumatoid Arthritis Figure 8. Juvenile Rheumatoid Arthritis Figure 9. Acute Pain Conditions Figure 10. Migraine Figure 11. Dysmenorrhea Figure 12. Global Rofecoxib Market Size 2015-2026 (US$ Million) Figure 13. Global Rofecoxib Sales Capacity (MT) (2015-2026) Figure 14. Global Rofecoxib Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Rofecoxib Sales Share by Manufacturers in 2020 Figure 16. Global Rofecoxib Revenue Share by Manufacturers in 2019 Figure 17. The Global 5 and 10 Largest Players: Market Share by Rofecoxib Revenue in 2019 Figure 18. Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Rofecoxib Sales Market Share by Region (2015-2020) Figure 20. Global Rofecoxib Sales Market Share by Region in 2019 Figure 21. Global Rofecoxib Revenue Market Share by Region (2015-2020) Figure 22. Global Rofecoxib Revenue Market Share by Region in 2019 Figure 23. North America Rofecoxib Sales Market Share by Country in 2019 Figure 24. North America Rofecoxib Revenue Market Share by Country in 2019 Figure 25. U.S. Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 26. U.S. Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Canada Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 28. Canada Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. Europe Rofecoxib Sales Market Share by Country in 2019 Figure 30. Europe Rofecoxib Revenue Market Share by Country in 2019 Figure 31. Germany Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 32. Germany Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. France Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 34. France Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. U.K. Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 36. U.K. Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Italy Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 38. Italy Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Russia Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 40. Russia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Asia Pacific Rofecoxib Sales Market Share by Region in 2019 Figure 42. Asia Pacific Rofecoxib Revenue Market Share by Region in 2019 Figure 43. China Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 44. China Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Japan Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 46. Japan Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. South Korea Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 48. South Korea Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. India Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 50. India Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Australia Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 52. Australia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Taiwan Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 54. Taiwan Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Indonesia Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 56. Indonesia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Thailand Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 58. Thailand Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Malaysia Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 60. Malaysia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Philippines Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 62. Philippines Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Vietnam Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 64. Vietnam Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Latin America Rofecoxib Sales Market Share by Country in 2019 Figure 66. Latin America Rofecoxib Revenue Market Share by Country in 2019 Figure 67. Mexico Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 68. Mexico Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Brazil Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 70. Brazil Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Argentina Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 72. Argentina Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Middle East and Africa Rofecoxib Sales Market Share by Country in 2019 Figure 74. Middle East and Africa Rofecoxib Revenue Market Share by Country in 2019 Figure 75. Turkey Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 76. Turkey Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Saudi Arabia Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 78. Saudi Arabia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. U.A.E Rofecoxib Sales Growth Rate (2015-2020) (MT) Figure 80. U.A.E Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Sales Market Share of Rofecoxib by Type (2015-2020) Figure 82. Sales Market Share of Rofecoxib by Type in 2019 Figure 83. Revenue Share of Rofecoxib by Type (2015-2020) Figure 84. Revenue Market Share of Rofecoxib by Type in 2019 Figure 85. Global Rofecoxib Sales Growth by Type (2015-2020) (MT) Figure 86. Global Rofecoxib Sales Market Share by Application (2015-2020) Figure 87. Global Rofecoxib Sales Market Share by Application in 2019 Figure 88. Global Revenue Share of Rofecoxib by Application (2015-2020) Figure 89. Global Revenue Share of Rofecoxib by Application in 2020 Figure 90. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Chengdu Meinkai Chemical Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Wuhan Xinxin Jiali Biotechnology Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Tremeau Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Price Trend of Key Raw Materials Figure 97. Manufacturing Cost Structure of Rofecoxib Figure 98. Manufacturing Process Analysis of Rofecoxib Figure 99. Rofecoxib Industrial Chain Analysis Figure 100. Channels of Distribution Figure 101. Distributors Profiles Figure 102. Porter's Five Forces Analysis Figure 103. North America Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026) Figure 104. North America Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Europe Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026) Figure 106. Europe Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Latin America Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026) Figure 108. Latin America Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Middle East and Africa Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026) Figure 110. Middle East and Africa Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Asia Pacific Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026) Figure 112. Asia Pacific Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Bottom-up and Top-down Approaches for This Report Figure 114. Data Triangulation Figure 115. Key Executives Interviewed

Merck Chengdu Meinkai Chemical Co. LTD Wuhan Xinxin Jiali Biotechnology Co. LTD Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Pfizer Tremeau